CLINICAL_TRIALS
trial_result
· 2011-09-21
Clinical Trial Update: Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease [Phase 3]
Summary
A Phase 3 efficacy trial evaluating AGSPT201 tablets for gastroesophageal reflux disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED